SCHEMBL7948828

SCHEMBL7948828

CN(C(=O)c1ccc2c(c1)CCCN2C(=O)CCc1ccc(C#N)cc1)C1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 1/20 0.45
TP53 P04637 2/20 0.44
PDK1 Q15118 3/20 0.40
PDK2 Q15119 3/20 0.40
PDK3 Q15120 3/20 0.40
PDK4 Q16654 3/20 0.40
POLB P06746 2/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC8 Q9BY41 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ACACB O00763 2/20 0.39
BRD4 O60885 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6986538 0.84 TP53 (0.49) TP53PDK1PDK2PDK3PDK4
SCHEMBL6978699 0.83 POLB (0.48) TP53PDK1PDK2PDK3PDK4
SCHEMBL7410530 0.82 TP53 (0.45) TP53PDK1PDK2PDK3PDK4
SCHEMBL7958782 0.82 IDO1 (0.45) ITKTP53PDK1PDK2PDK3
SCHEMBL6979177 0.82 CCR5 (0.39) ITKALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL6980414 0.81 TP53 (0.44) TP53HDAC1HDAC8HDAC6ALDH1A1
SCHEMBL6979174 0.81 TP53 (0.50) TP53HDAC1HDAC8HDAC6MEN1
SCHEMBL6981826 0.81 PDK1 (0.52) TP53PDK1PDK2PDK3PDK4
SCHEMBL6985246 0.81 TP53 (0.51) TP53PDK1PDK2PDK3PDK4
SCHEMBL7958428 0.80 MEN1 (0.46) TP53HDAC1HDAC8HDAC6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed